26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effect of Delayed Remote Ischemic Preconditioning on Acute Kidney Injury and Outcomes in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BACKGROUND:

          Remote ischemic preconditioning (RIPC) has 2 time windows for organ protection: acute and delayed. Previous studies have mainly focused on the organoprotective effects of acute RIPC. We aimed to determine whether delayed RIPC can reduce the occurrence of acute kidney injury (AKI) and postoperative complications in patients undergoing cardiac surgery.

          METHODS:

          This prospective, single-center, double-blind, randomized controlled trial involved 509 patients at high risk for AKI who were scheduled for elective cardiac surgery requiring cardiopulmonary bypass. Patients were randomized to receive RIPC (4 cycles of 5-minute inflation and 5-minute deflation on 1 upper arm with a blood pressure cuff) 24 hours before surgery or a sham condition (control group) that was induced by 4 cycles of 5-minute inflation to a pressure of 20 mm Hg followed by 5-minute cuff deflation. The primary end point was the incidence of AKI within the prior 7 days after cardiac surgery. The secondary end points included renal replacement therapy during hospitalization, change in urinary biomarkers of AKI and markers of myocardial injury, duration of intensive care unit stay and mechanical ventilation, and occurrence of nonfatal myocardial infarction, stroke, and all-cause mortality by day 90.

          RESULTS:

          A total of 509 patients (mean age, 65.2±8.2 years; 348 men [68.4%]) were randomly assigned to the RIPC group (n=254) or control group (n=255). AKI was significantly reduced in the RIPC group compared with the control group (69/254 [27.2%] versus 90/255 [35.3%]; odds ratio, 0.68 [95% CI, 0.47–1.00]; P=0.048). There were no significant between-group differences in the secondary end points of perioperative myocardial injury (assessed by the concentrations of cardiac troponin T, creatine kinase myocardial isoenzyme, and NT-proBNP [N-terminal pro-brain natriuretic peptide]), duration of stay in the intensive care unit and hospital, and occurrence of nonfatal myocardial infarction, stroke, and all-cause mortality by day 90.

          CONCLUSIONS:

          Among high-risk patients undergoing cardiac surgery, delayed RIPC significantly reduced the occurrence of AKI.

          REGISTRATION:

          URL: https://www.chictr.org.cn; Unique identifier: ChiCTR2000035568.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: found

          KDIGO Clinical Practice Guidelines for Acute Kidney Injury

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment

            Cardiac surgery-associated acute kidney injury (CSA-AKI) is the most common complication in adult patients undergoing open heart surgery. In this Review, the authors discuss the definition, epidemiology, pathophysiology and risk factors of CSA-AKI. The authors also explore the use of novel biomarkers of AKI and their potential utility in preventing or treating CSA-AKI.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Acute kidney injury following cardiac surgery: current understanding and future directions

              Acute kidney injury (AKI) complicates recovery from cardiac surgery in up to 30 % of patients, injures and impairs the function of the brain, lungs, and gut, and places patients at a 5-fold increased risk of death during hospitalization. Renal ischemia, reperfusion, inflammation, hemolysis, oxidative stress, cholesterol emboli, and toxins contribute to the development and progression of AKI. Preventive strategies are limited, but current evidence supports maintenance of renal perfusion and intravascular volume while avoiding venous congestion, administration of balanced salt as opposed to high-chloride intravenous fluids, and the avoidance or limitation of cardiopulmonary bypass exposure. AKI that requires renal replacement therapy occurs in 2–5 % of patients following cardiac surgery and is associated with 50 % mortality. For those who recover from renal replacement therapy or even mild AKI, progression to chronic kidney disease in the ensuing months and years is more likely than for those who do not develop AKI. Cardiac surgery continues to be a popular clinical model to evaluate novel therapeutics, off-label use of existing medications, and nonpharmacologic treatments for AKI, since cardiac surgery is fairly common, typically elective, provides a relatively standardized insult, and patients remain hospitalized and monitored following surgery. More efficient and time-sensitive methods to diagnose AKI are imperative to reduce this negative outcome. The discovery and validation of renal damage biomarkers should in time supplant creatinine-based criteria for the clinical diagnosis of AKI.
                Bookmark

                Author and article information

                Contributors
                Journal
                Circulation
                Circulation
                CIR
                Circulation
                Lippincott Williams & Wilkins (Hagerstown, MD )
                0009-7322
                1524-4539
                25 September 2024
                22 October 2024
                : 150
                : 17
                : 1366-1376
                Affiliations
                [1]Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).
                [2]Department of Cardiovascular Surgery (Q.J., C.W.), Zhongshan Hospital, Fudan University, Shanghai.
                [3]Cardiac Intensive Care Center (Y.S., Z.L.), Zhongshan Hospital, Fudan University, Shanghai.
                Author notes
                Correspondence to: Xiaoqiang Ding, MD, PhD, Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China, Email ding.xiaoqiang@ 123456zs-hospital.sh.cn
                Chunsheng Wang, MD, Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China, Email wang.chunsheng@ 123456zs-hospital.sh.cn
                Zhe Luo, MD, Cardiac Intensive Care Center, Zhongshan Hospital, Fudan University, Shanghai, China, Email luo.zhe@ 123456zs-hospital.sh.cn
                Author information
                https://orcid.org/0000-0002-0608-161X
                https://orcid.org/0000-0001-5835-3405
                https://orcid.org/0000-0002-2191-0711
                https://orcid.org/0000-0002-7198-2027
                https://orcid.org/0009-0000-2619-0293
                https://orcid.org/0000-0001-8355-4903
                https://orcid.org/0000-0003-4925-2770
                https://orcid.org/0009-0008-4582-5897
                https://orcid.org/0000-0003-4954-8539
                Article
                CIRCULATIONAHA2024071408D 00010
                10.1161/CIRCULATIONAHA.124.071408
                11495536
                39319450
                d5d5d745-73de-47c8-93d1-0ea64ee41a6a
                © 2024 The Authors.

                Circulation is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.

                History
                : 16 July 2024
                : 4 September 2024
                Categories
                10021
                10039
                10143
                Original Research Articles
                Custom metadata
                TRUE
                T

                acute kidney injury,biomarkers,cardiac surgical procedures,ischemic preconditioning

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content162

                Cited by2

                Most referenced authors713